Fluorimetric study on a novel FDA-approved combination used for the treatment of overactive bladder syndrome in different matrices

•A brand-new combination for treating overactive bladder syndrome.•Two proposed ultrasensitive fluorimetric techniques.•Simultaneous analysis of mirabegron and solifenacin succinate at nanogram scale.•The proposed techniques were validated as per ICH guidelines.